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Summary 
Although the clinical effect of intra-articular administration of the Hyaluronic Acid (HA) for the treatment of 
osteoarthritis knee joint has been widely recognized, the efficacy of mechanical tribology function of HA as a 
viscosupplementation to joint lubrication has not yet been confirmed.  
To examine in vivo the effects of enhancement of tribology function of joint lubricant for the treatment of 
osteoarthritis, high viscous Polyethylene Glycol (PEG) was synthesized as an artificial lubricant, and animal 
experiment was performed. Experimental osteoarthritis models of the both of knee joints of three rabbits were 
induced by meniscsectomy and cartilage defects. These animals were subjected to monthly intra-articular 
cartilage injection of PEG lubricant to one side knee joint ( another side was not injected as a control knee ), and 
were sacrificed at 3 month after operation. The extracted knee joints were evaluated macroscopically and 
histologically.  
As a results, the PEG  injected knees had a  tendency  to demonstrate  less damage of articular cartilage 
compared with the control group. This finding indicated that the development of mechanical lubricant system 
by PEG for the preventing of articular cartilage wear could have potential to be one of effective treatment for 
arthritis. 
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1． INTRODUCTION 
Osteoarthritis (OA), the most common form of arthritis, is 
a chronic disease characterized by the slow degradation of 
cartilage, pain and increasing disability. The disease can 
have an impact on several aspects of a patient's life, 
including function and activities of daily life, relationships, 
economic status, body image and emotional wellbeing1,2). 
Orthopedic procedures are important in the management 
of OA and should not be reserved only for late severe 
disease.  
Although Total knee arthroplasty (TKA) is representative 
procedure for OA knee associated with severe deformity, 
current conservative therapies for moderate OA are drug 
therapy, physical therapy, muscle exercise, and therapy and 
rehabilitation. These goals of most patients is the relief of 
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pain and localized stiffness, as well as the prevention of 
deformity and associated limitation of motion. 
As another treatment of OA knee joint, the intra-articular 
injection method of high-molecular-weight hyaluronic acid 
(HA) has recently become more widely accepted for relief 
from pain. HA is responsible for the viscoelastic properties 
of synovial fluid, a highly viscous fluid. Its mechanism of 
action includes two types: one involves the biomechanics 
system, the enhancement of articular lubrication and fluid 
viscosity, while the other involves the biological and 
biochemical system, the inhibition of inflammatory agents 
such as PGE2, NO and the suppression of proteoglycan from 
cartilage matrix 3-5). 
This concept of the intra-articular injection of hyaluronic 
acid for OA is also reasonable given the tribology theoretical 
background; however, hyaluronic acid is easily degraded in 
articular joints according to recent studies. Therefore, new 
materials with excellent biocompatibility, durability, 
rheology and lubricative function are desired instead of 
hyaluronic acid.  
Against this background, we have synthesized and 
developed Polyethylene Glycol (PEG) sol as a new 
intra-articular lubricant for medical treatment for OA knee6). 
In present study, the efficacy of this PEG lubricant has 
been accessed by the animal experiment using the rabbits. 
 
2．Materials and Methods 
2.1 Materials 
2.1.1 The fabrication and characteristics of PEG 
lubricant 
 
PEG is a polymer with the chemical formula 
HO-(CH2CH2OH) n-H, which refers to a chemical 
compound composed of repeating ethylene glycol units  as 
shown in Fig.1. It has long been manufactured industrially 
and utilized in many applications, such as nonionic 
surfactants, lubricants, as an intermediate for urethane 
composition, adhesives and cosmetics.  
Furthermore, PEG is non-toxic and biocompatible 
material, PEG is thus also used for bio-related applications, 
such as pharmaceutical formulations, aqueous two-phase 
partitions, as a precipitant for plasmid DNA isolation, 
protein crystallization and cell fusion. We have also paid 
attention this advantage, attempted to synthesized the PEG 
lubricant.   
 
 
 
Fig.1 The polyethylene glycol (PEG) molecular structure. 
 
 
As an artificial lubricant, PEG (molecular weight:      
2 million) powder was prepared, dissolved in distilled water, 
heated and synthesized to 6wt.% PEG hydrate sol material, 
as shown in Figure 2. 
 
 
 
 
 
 
 
 
 
 
      
  
   
 
Fig.2  Polyethylene glycol (PEG) lubricant. 
        (PEG 6 wt% sol ) 
 
 
This water glycol hydraulic fluid has a three-dimensional 
network structure with H2O molecules and high 
viscoelasticity. 
 
2.1.2 Viscosity of PEG lubricant 
The measured viscosities of this PEG lubricant and human 
synovial fluid are shown and compared in Figure 3. PEG 
lubricant has high viscosity (about 280 dPa·stp) compared 
with synovial fluid, and shows non-Newtonian fluid changes 
depending on the shear rate.    
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Fig.3   The Correlation of the viscosity and Shear rate of 
two kinds of lubricants (PEG lubricant and human 
synovial fluid) 
 
 
2.2 Method 
2.2.1  knee OA model of rabbits 
Prior to an experiment on intra-articular injections of PEG, 
knee OA model rabbits were prepared by a surgical 
procedure producing a cartilage defect in the femoral 
condyle and meniscectomy, followed by three months of 
postoperative progress.  
As shown in Figure 4, the rabbits  knee joints of these 
experimental rabbits exhibit features reflecting the early 
appearance of osteoarthritis, such as progressive cartilage 
wear of the tibia and femoral cartilage defect (shown by 
arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4  Macro-appearance of Osteoarthritis (OA) model of 
the knee joint of rabbits 
 
2.2.2  In vivo trial of intra-articular 
lubricants for osteoarthritis of the knee 
While PEG lubricant was injected into one knee joint 
once a month for three months, the other side, used as a 
control, was not injected; after that the rabbits were then 
sacrificed, and the cartilage of the knee was examined 
macroscopically and histologically. 
3．Result 
3.1  macroappearance 
Figure 5 shows the macroappearance of the articular 
cartilage in knees of the control group and the PEG-injected 
group (PEG group). In the PEG group, there were no 
significant changes in the cartilage in both femur and tibia 
compared with the cartilage before injection. In contrast, 
apparent erosion and some progression of deformation, 
including cartilage defect (arrows), were observed in the 
tibial cartilage of the control group, as shown in Fig. 5 (a)-2. 
 
 
 
Fig.5  Micro photographs of rabbits knee joints for 
3months under PEG injection 
(a)-1 femoral cartilage    (a)-2 tibia cartilage 
                               in Control group 
(b)-1 femoral cartilage    (b)-2 tibia cartilage 
                               in PEG group 
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3.2 Histological finding 
Figure 6 shows the results of the histological photographs 
of tibial articular cartilage. Although partial mild disturbance 
is observed on the cartilage surface in the PEG group, the 
cartilage surface itself is maintained. In contrast, in the 
control group, the cartilage is in a poor state, with thinning 
and partial delamination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6.  Histological photographs of rabbits knee joints for 
3months under PEG injection 
(a)-1 femoral cartilage    (a)-2 tibia cartilage 
                                   in Control group 
(b)-1 femoral cartilage    (b)-2 tibia cartilage 
                                    In PEG group 
 
4．Discussion 
According to the pathophysiology of osteoarthritis of knee 
joints, OA is characterized by the slow degradation of 
cartilage over several years. In normal cartilage, a delicate 
balance exists between matrix synthesis and degradation; in 
contrast, OA cartilage degradation exceeds the rate of 
synthesis or regeneration. The balance is affected and 
regulated by several factors, such as age and weight.    
Considering that biomechanical stress also belongs to this 
group of factors, it would be highly effective for the 
medication and prevention of osteoarthritis to improve the 
biomechanical and tribological circumstances of the 
cartilage in knee joints by the use of an appropriate lubricant. 
This experimental result supports this concept.  
Moreover, PEG mixed synovial fluid exhibited the best 
result. As this mechanism, interaction between the PEG 
molecules and proteins in the synovial fluid is also suspected. 
It is well known that these proteins in the synovial fluid, 
especially albumin, have a very important role in boundary 
lubrication in synovial joints7). The protein molecules can 
adsorb on cartilage surface as a wear-protective layer and 
form an excellent lubrication system. On the other hand, 
since PEG molecules are also organic compounds having a 
hydroxyl group at one or both ends of the molecules8), 
boundary lubricating film would be formed between 
lubricant surfaces9,10). The improved lubrication mode by 
two different types of functional lubricant might prevent OA 
progression, although the details of the mechanism involved 
are unclear. 
The results of our in vivo study strongly suggested that a 
lubricant involving a mixture of PEG hydraulic fluid and 
synovial fluid could effectively protect against OA 
progression in the knee joint. Though further study 
regarding the details of the lubrication mechanism of 
synovial fluid mixed with PEG is necessary, in future, by 
modifying other functional compounds at one or both ends 
of the PEG molecules, even better intra-articular injection of 
PEG lubricant could be developed for OA treatment. 
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